Yamanouchi Venture Capital
4
17M
2
0.50
2
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented VC is situated in the Palo Alto.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Yamanouchi Venture Capital, startups are often financed by OrbiMed, Yozma Group, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Dansk Innovation, Aravis Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, Dansk Innovation, Aravis Ventures.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. Among the most successful fund investment fields, there are Biotechnology, Wellness. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Evolva.
The increased amount of exits for fund were in 2009. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Yamanouchi Venture Capital works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.50
- Investments by industry
- Health Care (4)
- Wellness (3)
- Consulting (3)
- Biotechnology (3)
- Food and Beverage (3) Show 2 more
- Investments by region
-
- United States (1)
- Switzerland (3)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Predix Pharmaceuticals | 27 Jan 2005 | Health Care, Medical, Pharmaceutical | Late Stage Venture | 43M | United States, Boston, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.